Cargando…
Laboratory and clinical studies of a new antibiotic, cephaloridine, in the treatment of gram-positive infections.
Autores principales: | Thornton, G. F., Andriole, V. T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1966
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2591244/ https://www.ncbi.nlm.nih.gov/pubmed/4382527 |
Ejemplares similares
-
Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections.
por: Boyer, J. L., et al.
Publicado: (1968) -
Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections
por: Brade, Karrine D., et al.
Publicado: (2016) -
Assessment of the Susceptibility of Clinical Gram-Negative and Gram-Positive Bacterial Strains to Fosfomycin and Significance of This Antibiotic in Infection Treatment
por: Kowalska-Krochmal, Beata, et al.
Publicado: (2022) -
Cephalexin: clinical and laboratory studies.
por: Lyons, R. W., et al.
Publicado: (1971) -
New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis
por: Bloem, Annemieke, et al.
Publicado: (2021)